Ethics and Collateral Findings in Pragmatic Clinical Trials.

Published

Journal Article

Pragmatic clinical trials (PCTs) offer important benefits, such as generating evidence that is suited to inform real-world health care decisions and increasing research efficiency. However, PCTs also present ethical challenges. One such challenge involves the management of information that emerges in a PCT that is unrelated to the primary research question(s), yet may have implications for the individual patients, clinicians, or health care systems from whom or within which research data were collected. We term these findings as ?pragmatic clinical trial collateral findings,? or ?PCT-CFs?. In this article, we explore the ethical considerations associated with the identification, assessment, and management of PCT-CFs, and how these considerations may vary based upon the attributes of a specific PCT. Our purpose is to map the terrain of PCT-CFs to serve as a foundation for future scholarship as well as policy-making and to facilitate careful deliberation about actual cases as they occur in practice.

Full Text

Duke Authors

Cited Authors

  • Morain, SR; Weinfurt, K; Bollinger, J; Geller, G; Mathews, DJ; Sugarman, J

Published Date

  • January 2020

Published In

Volume / Issue

  • 20 / 1

Start / End Page

  • 6 - 18

PubMed ID

  • 31896322

Pubmed Central ID

  • 31896322

Electronic International Standard Serial Number (EISSN)

  • 1536-0075

Digital Object Identifier (DOI)

  • 10.1080/15265161.2020.1689031

Language

  • eng

Conference Location

  • United States